As women navigate midlife and menopause, many explore natural supplements like lion’s mane mushroom (Hericium erinaceus) for various aspects of well-being. While interest in its potential benefits is growing, it’s important to consider how it might interact with other medications you may be taking.
Understanding potential lion’s mane drug interactions is crucial for informed decision-making. This article will discuss what the current evidence suggests, particularly concerning blood thinners and other common medications, while emphasizing the limited nature of current research.
Understanding Lion’s Mane Mushroom
Lion’s mane is a type of edible mushroom that has been traditionally used in some cultures. Recent research has begun to explore various components of Hericium erinaceus, including its polysaccharides and peptides [1][2]. Some studies are investigating its potential influence on areas like the gut-brain axis and mood-related outcomes [3].
The mushroom contains compounds such as erinacines, which are being studied for their potential roles in microglial regulation and other areas [4]. Other research has looked at its neuroprotective activity, sometimes in combination with other extracts [5]. Constituents of Hericium erinaceus are also being explored for their potential to target specific receptors in the body [6].
Lion’s Mane and Blood Thinners: Limited Evidence
One of the most frequently asked questions regarding lion’s mane drug interactions concerns its potential effects on blood clotting and interactions with blood-thinning medications. These medications, also known as anticoagulants or antiplatelet drugs, are commonly prescribed to women in midlife and beyond for various cardiovascular conditions.
Currently, no published human trial has given lion’s mane alongside a blood thinner and measured what happens. That gap is real, and it is the honest starting point. It is not the same as saying nothing is known, because laboratory work on lion’s mane and platelet function does exist and is set out below. Most of the wider lion’s mane literature examines other questions entirely, such as gut-brain axis modulation, mood and molecular mechanisms [3][1][2][4][5][6].
The evidence that does exist is laboratory evidence rather than anecdote, and it points in one direction rather than being neutral. A 2010 study in Phytomedicine reported that an ethanol extract of Hericium erinaceus potently inhibited platelet aggregation triggered by collagen, then isolated the compound responsible and identified it as hericenone B. The effect was selective: hericenone B blocked collagen-induced aggregation but did not suppress aggregation induced by ADP, thrombin, adrenaline or a thromboxane analogue, and the authors confirmed the collagen effect in human platelets as well as rabbit platelets [7]. Inhibiting platelet aggregation is the same broad action many antiplatelet drugs are prescribed for, which is a plausible mechanism for adding to their effect rather than opposing it.
A 2019 screen published in Nutrients puts a boundary on that. It tested hot water extracts of eight edible mushroom species, including Hericium erinaceus, against human platelets. Lion’s mane was not among the species showing the strongest antiplatelet activity, and none of the eight extracts altered prothrombin time, prothrombin ratio or INR, the measures used to monitor warfarin therapy [8]. The two studies also used different extracts, ethanol in 2010 and hot water in 2019, which is the same distinction that separates many of the products on a shelf.
Putting those together honestly: no human trial has tested the combination, standard clotting-time measures were unchanged in vitro, and the one isolated lion’s mane compound studied for this purpose inhibits platelet aggregation in human platelets. That is not proof of harm, and it is not a blank absence of evidence either. If you take warfarin, clopidogrel, aspirin, a direct oral anticoagulant or any other antiplatelet or anticoagulant medication, this is a conversation to have with your prescriber before you start lion’s mane, not after.
It is essential to approach this with caution, because altered blood clotting carries serious health implications.
Other Potential Drug Interactions: What We Don’t Know
Beyond blood thinners, women in midlife often take a range of medications for conditions related to hormonal changes, bone health, mood, and more. Most lion’s mane research addresses its biotransformation, gut microbiota interactions and specific molecular targets [3][1][6]. However, none of the available evidence directly addresses interactions with other classes of medications like hormone replacement therapy, antidepressants, blood pressure medications, or diabetes drugs.
The current body of research is primarily focused on understanding the mushroom’s components and their potential biological activities at a foundational level [2][4]. This early stage of research means that comprehensive studies on drug interactions are not yet available. Therefore, while lion’s mane is being explored for its potential effects, specific interaction data with the vast majority of commonly prescribed medications is currently absent.
It is important to recognize that even natural compounds can influence drug metabolism pathways in the body. Without specific research, it is not possible to predict all potential interactions. This highlights the importance of open communication with your healthcare provider about all supplements you are considering.
Two further findings are worth knowing, because both are more concrete than that general caution. A 2025 toxicological assessment in Frontiers in Toxicology tested a commercial organic lion’s mane powder in rats under OECD guidelines and found no acute toxicity, no evidence of subchronic oral toxicity at doses up to 2,000 mg per kilogram of body weight per day, and no genotoxicity in either in vitro or in vivo assays [9]. That is reassuring about the ingredient itself. It is animal data, so it speaks to basic safety rather than to how lion’s mane behaves alongside a prescription drug.
The second is a caution about blended products. A 2025 case report describes a 43-year-old woman with metastatic colorectal cancer who was found to have grade 3 hepatic cytolysis and cholestasis before a chemotherapy cycle. She had been taking a mushroom powder supplement containing both Agaricus blazei and lion’s mane. Her chemotherapy was cancelled, and her liver function improved after she stopped the supplement. The authors attributed the liver injury to the Agaricus blazei, not to the lion’s mane [10]. The point is not that lion’s mane harmed this patient, because the report says it did not. The point is that blended mushroom capsules are common, that what sits on the label next to lion’s mane matters, and that any supplement taken during cancer treatment needs to be disclosed to the treating team.
Navigating Supplement Use with Medications
Given the limited evidence on lion’s mane drug interactions, particularly for women navigating midlife and menopause who may be on multiple medications, a cautious approach is recommended. The available studies are exploring the mushroom’s potential effects on the gut-brain axis, mood, and specific molecular pathways [3][6], but do not provide interaction data.
Before adding lion’s mane or any new supplement to your routine, especially if you are taking prescription medications, it is advisable to consult with your doctor or pharmacist. They can review your complete medication list and help you assess any potential risks based on what is currently known, or unknown, about lion’s mane.
Your healthcare provider is best positioned to offer personalized guidance, considering your individual health profile and medication regimen. They can help you weigh any potential benefits against the unknown risks of interactions.
References
- Recent insights into Hericium erinaceus polysaccharides: Gastrointestinal, gut microbiota, microbial metabolites, overall health and structure-function correlation. International journal of biological macromolecules, 2025
- Unraveling novel umami peptides in Hericium erinaceus and its umami mechanism by ion exchange chromatography, peptidomics and molecular dynamics simulations. Food research international (Ottawa, Ont.), 2025
- Biotransformation of Ganoderma lucidum and Hericium erinaceus for ex vivo gut-brain axis modulation and mood-related outcomes in humans: CREB/BDNF signaling and microbiota-driven synergies. Journal of ethnopharmacology, 2025
- Exploring the Synergistic Effects of Erinacines on Microglial Regulation and Alzheimer’s Pathology Under Metabolic Stress. CNS neuroscience & therapeutics, 2024
- Enhancement of the neuroprotective activity of Hericium erinaceus mycelium co-cultivated with Allium sativum extract. Archives of physiology and biochemistry, 2015
- Phytoconstituents of Hericium erinaceus Exert Benefits for ADHD Conditions by Targeting SLC6A4: Extraction, Spectroscopic Characterization, Phytochemical Screening, In Vitro, and Computational Perspectives. ACS omega, 2025
- Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2010
- The Effect of Mushroom Extracts on Human Platelet and Blood Coagulation: In vitro Screening of Eight Edible Species. Nutrients, 2019
- A toxicological assessment of Hericium erinaceus (Lion’s mane) and Trametes versicolor (Turkey tail) mushroom powders. Frontiers in toxicology, 2025
- Grade 3 cytolysis in a patient with metastatic colorectal cancer consuming a mushroom powder-based alternative therapy. Journal of oncology pharmacy practice, 2025
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.